jsharpe

About Jenny Sharpe

This author has not yet filled in any details.
So far Jenny Sharpe has created 286 blog entries.

African Medicines Agency (AMA): Origins, Evolution and Future Prospects

This poster was presented at DIA 2026 and examines the development of the African Medicines Agency (AMA), tracing its evolution from the African Medicines Regulatory Harmonisation (AMRH) Programme to its [...]

2026-08-03T11:06:26+00:00August 6th, 2026|Tags: , , |

CIRS 2025 Annual Report

The CIRS 2025 Annual Report highlights a year of independent research, global stakeholder engagement and evidence-based insights aimed at advancing regulatory and health technology assessment (HTA) policies and processes. Inside [...]

2026-07-29T10:25:42+00:00July 29th, 2026|Tags: |

CIRS R&D Briefing 105 – HTA Landscape under the EU HTA Regulation

Baseline mapping of national HTA authorities across the EU and EEA The EU Health Technology Assessment Regulation (HTAR) has moved from policy to practice, with Joint Clinical Assessments (JCAs) [...]

2026-07-22T09:12:10+00:00July 22nd, 2026|Tags: , |

Comparative review of 10 HTA systems – Dai 2026

Overview Health technology assessment (HTA) plays a key role in supporting evidence-informed healthcare decision making, pricing, reimbursement, and coverage decisions worldwide. As countries seek to strengthen health policy and [...]

2026-07-22T08:06:00+00:00July 16th, 2026|Tags: |

Q2 2026 Newsletter

We are pleased to share the latest CIRS newsletter with you, providing an update on our recent activities, research outputs, and upcoming work across medicine regulation and HTA. 🔍In [...]

2026-06-30T10:27:34+00:00July 6th, 2026|

CIRS RD Briefing 106 – New drug approvals by six major authorities 2016-2025

Overview This R&D Briefing presents the Centre for Innovation in Regulatory Science (CIRS) annual analysis of new active substance (NAS) approvals by six major regulatory authorities: the European Medicines [...]

Go to Top